Mar 27, 2017 at 15:51 | Source: CNBC-TV18
According to Gaurang Shah of Geojit Financial Services, one may prefer Cipla and Aurobindo Pharma.
Mar 24, 2017 at 17:19 | Source: CNBC-TV18
With the Finance Minister categorically stating that they will resolve the NPA issues, the trajectory for PSU Banks looks good, said Mehraboon Irani of Nirmal Bang Securities.
Mar 08, 2017 at 12:11 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma stocks like Divis Lab, Cipla, Alembic Pharma, Strides Shasun, Ajanta Pharma and Torrent Pharma will get astro support.
Mar 08, 2017 at 08:00 | Source: CNBC-TV18
Cipla | Tata Motors | Kotak Mahindra Bank | Tata Steel | Hero Motocorp | Infosys | Wockhardt | Vista Pharma | Kellton Tech | Dilip Buildcon | Nestle | Cadila Healthcare | Gujarat Fluorochemicals and DB Corp are stocks, which are in the news today.
Mar 06, 2017 at 09:21 | Source: Moneycontrol.com
Under the agreements, the company will divest its 100 percent stake in Cipla Agrimed Proprietary and Cipla Vet Proprietary, South Africa.
Mar 06, 2017 at 08:00 | Source: CNBC-TV18
Cipla | Bharat Forge | Tata Steel | SBI | PNB | Bharti Airtel | UltraTech Cement | Jaiprakash Associates | Aditya Birla Nuvo | Shree Cement | Religare Enterprises | ARSS Infra | Srei Infrastructure | GMR Infrastructure and SAIL are stocks, which are in the news today.
Mar 05, 2017 at 12:07 | Source: Moneycontrol.com
Cipla, India's fifth largest drug maker by sales on Sunday said that it has entered into agreements, through its wholly owned subsidiary Inyanga Trading with Ascendis Health to sell its animal health business in South Africa and Sub-Saharan Africa.
Mar 05, 2017 at 11:57 | Source: Moneycontrol.com
Cipla has made many changes to its top leadership as it tries to catch up with other larger Indian generic rivals like Sun Pharma, Dr.Reddys, Lupin and Aurobindo in the US market who generate half their sales at much higher margins.
Mar 02, 2017 at 14:47 | Source: CNBC-TV18
CNBC-TV18's Ekta Batra lists out stocks that you should focus on.
Mar 02, 2017 at 13:33 | Source: CNBC-TV18
Umang Vohra of Cipla reasoned that almost 80 percent of the drugs sold by Cipla in the US market are manufactured in the US itself. He said it will not be a challenge to manufacture all its supplies in the US itself if asked to do so by authorities.